Lymphoma Program
The Lymphoma Clinical Oncology Group is a research-based program offering comprehensive cancer care to patients with lymphoid malignancies including relapsed, refractory, and poor-prognosis disease. Using advanced and innovative treatment approaches, our group provides individualized care based on the specific needs of the patient and in collaboration with the referring physician.
Special Services and Diagnostic Tests
- A full complement of blood banking services including HLA-matched platelets for patients undergoing marrow transplantation
- Magnetic resonance, computer tomography and nuclear medicine imaging
- Cytogenetics
- Molecular diagnostic tests
- Flow cytometry
- Specialized immunologic tissue staining and cytology
Research Interests
- Novel immunologic and pharmacologic strategies to eliminate minimal residual disease following tumor-reductive therapy
- Administration of high-dose chemotherapy with peripheral blood stem cell transplantation for relapsed or poor-prognosis disease, both autologous and allogeneic stem cell sources
